FRANKLIN LAKES, N.J.,
Aug. 3, 2020 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE: BDX), a leading global
medical technology company, today issued its 2019 Sustainability
Report, focusing on performance of the environmental, social
and governance factors that support the company's 2020
Sustainability Goals from October 1,
2018 to September 30, 2019 (FY
2019).
BD's sustainability strategy is driven by its purpose –
Advancing the world of health™ – and provides the framework
for how it manages, and makes an impact on, the most relevant
social and environmental issues for the company and its
stakeholders.
- Innovation – contributing to more sustainable health
care systems by improving outcomes, reducing costs and protecting
patients and health care workers
- Access – supporting health system improvements in
emerging and developing economies, and reaching vulnerable
populations globally
- Efficiency – working across the value chain to reduce
environmental impacts and create positive social impact
- Empowerment – advancing a purpose-driven culture through
workforce and community engagements
Highlights from this year's report include:
- Innovation: In FY 2019, BD launched 25 products across
the company's three businesses – Medical, Interventional and Life
Sciences – further increasing access to quality health care. The
company continues to identify opportunities for innovation to help
address health care challenges and drive business performance.
- Access: In August 2019, BD
was recognized for its third time in five years by Fortune
magazine, and named to its "Change the World List" for the
company's extensive efforts in helping combat the threat of
antimicrobial resistance (AMR) through programs that raise
awareness of AMR, as well as mobilize the health care industry,
leaders and communities around the world to take action to extend
the useful life of medications.
- Efficiency: Since setting its 2020 Sustainability
targets in 2015, BD has continued to reduce its greenhouse gas
emissions and water consumption, and remains committed to waste
reduction, and increasing use of renewable energy, including the
installation of on-site solar power generation across BD's sites –
most recently at the company's global headquarters in Franklin Lakes, NJ. Over the course of FY
2019, the company identified more than 200 energy reduction
projects that will amount to over $5
million in energy savings, once completed. Projects include
the replacement of existing lighting with LED lighting,
recommissioning of an ice plant, combined heat and power projects,
installation of solar panel projects and various equipment
upgrades.
- Empowerment: BD is committed to fostering an environment
that welcomes and empowers an inclusive and diverse workforce which
has earned the company recognition by a number of organizations in
2019, including the Human Rights Campaign Foundation (Best Place to
Work for LGBTQ Equality), Bloomberg (2020 Gender Equality Index),
and Forbes (Best Employers for Diversity 2020), among others. The
company continues to place a strong focus on philanthropy,
providing $10 million in cash
donations and $14 million in product
donations, as well as expertise and employee volunteer hours to
non-profit organizations around the world.
"We are proud of our accomplishments in FY 2019, but we will
never be satisfied with maintaining the status quo," said
Tom Polen, CEO and president. "Just
as we continuously seek new innovations to help more patients live
better lives, we strive to be the best employer, the best
environmental steward and the best global corporate citizen we can
possibly be."
The company will announce new sustainability commitments later
in FY 2021 which will focus on shared value creation – addressing
unmet societal needs through business models and initiatives that
also contribute to commercial success. For more information about
the company's sustainability goals, view the 2019
Sustainability Report here:
https://www.bd.com/en-us/company/sustainability-at-bd.
About BD
BD is one of the largest global medical technology companies in
the world and is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. The company
supports the heroes on the frontlines of health care by developing
innovative technology, services and solutions that help advance
both clinical therapy for patients and clinical process for health
care providers. BD and its 65,000 employees have a passion and
commitment to help enhance the safety and efficiency of clinicians'
care delivery process, enable laboratory scientists to accurately
detect disease and advance researchers' capabilities to develop the
next generation of diagnostics and therapeutics. BD has a presence
in virtually every country and partners with organizations around
the world to address some of the most challenging global health
issues. By working in close collaboration with customers, BD can
help enhance outcomes, lower costs, increase efficiencies, improve
safety and expand access to health care. For more information on
BD, please visit bd.com.
Contacts:
|
|
Jessica
Offerjost
|
Monique N.
Dolecki
|
BD Public
Relations
|
BD Investor
Relations
|
201-258-0964
|
201.847.5378
|
Jessica.Offerjost@bd.com
|
Monique_Dolecki@bd.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bd-releases-fy-2019-sustainability-report-301104250.html
SOURCE BD (Becton, Dickinson and Company)